- US-listed companies
- Novo Integrated Sciences, Inc.
- Balance sheet
Novo Integrated Sciences, Inc. (NVOS) Balance sheet
Market cap
$76.95K
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/08 | 2018/08 | 2019/08 | 2020/08 | 2021/08 | 2022/08 | 2023/08 | 2024/08 | |
| Cash and cash equivalents | - | 6,293 | 3,423 | 1,831 | 14,123 | 54,350 | 2 | 675,705 | 2 | 2 | 8 | 2 | 416,323 | 844,584 |
| Total cash & short-term investments | - | 6,293 | 3,423 | 1,831 | 14,123 | 54,350 | 2 | 675,705 | 2 | 2 | 8 | 2 | 416,323 | 844,584 |
| Accounts receivable, net | - | - | - | - | - | - | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 |
| Inventories | - | - | - | - | - | - | - | - | - | - | 339,385 | 879,033 | 1 | 1 |
| Total current assets | 18,756 | 16,998 | 345,008 | 1,831 | 14,123 | 56,080 | 4 | 3 | 4 | 4 | 11 | 6 | 4 | 5 |
| Property, plant and equipment, net | 7,056 | 17,538 | 12,711 | 7,011 | - | - | 302,951 | 400,321 | 410,188 | 353,660 | 6 | 6 | 5 | 5 |
| Total assets | 25,812 | 34,536 | 357,719 | 22,592 | 27,873 | 69,830 | 6 | 5 | 32 | 35 | 62 | 41 | 36 | 32 |
| Accounts payable | 116,290 | 118,098 | 146,143 | 82,550 | 13,120 | 19,658 | 2 | 1 | 1 | 883,773 | 1 | 2 | 4 | 3 |
| Total current liabilities | 141,089 | 241,561 | 557,747 | 340,664 | 13,120 | 19,658 | 4 | 3 | 3 | 3 | 8 | 14 | 8 | 15 |
| Long-term debt, non-current | - | 590,331 | 747,839 | 307,598 | - | - | - | - | - | - | - | - | - | - |
| Total liabilities | 2 | - | - | - | - | - | 10 | 5 | 7 | 6 | 18 | 19 | 11 | 18 |
| Retained earnings | - | - | - | -19,452,612 | -22,223,326 | -22,388,213 | -9,091,977 | -11,199,989 | -11,591,973 | -16,507,127 | -20,969,274 | -53,818,489 | -67,033,041 | -83,199,785 |
| Stockholders' equity | -2,328,111 | -797,356 | -947,867 | -625,670 | 14,753 | 50,172 | -4,267,653 | 201,391 | 26 | 30 | 44 | 22 | 25 | 15 |
| Working capital | - | - | - | - | - | - | - | - | - | - |